Autoimmunity (or Not) in Atopic Dermatitis

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2019 Sep 26

PMID 31552053

Citations 17

Authors

Lennart M Roesner

Thomas Werfel

Affiliations

Soon will be listed here.

Abstract

Atopic dermatitis (AD), one of the most frequent inflammatory skin diseases worldwide, is believed to result from a disturbed skin barrier as well as aberrant immune reactions against harmless allergens. Starting mostly during childhood with a chronic, remitting relapsing course, the disease can persist into adulthood in about one fifth of patients. Immune reactions to self-proteins have been observed in AD patients already in the beginning of the Twentieth century, when human cellular extracts were shown to provoke skin lesions. However, the term "autoimmunity" has never been claimed, since AD is first and foremost an atopic disease. In contrast, this IgE-hallmarked autoreactivity was termed "autoallergy" and is ongoing discussed regarding its impact on the disease. Since severely affected patients tend to develop IgE-hypersensitivity reactions to numerous environmental allergens, the impact of immune responses to self-proteins is difficult to determine. On the other hand: any autoreactivity, irrespective of the magnitude, implicates the potential of driving the chronification of the disease while shaping the immune response. This review article revisits the observations made on autoallergy from an actual point of view and tries to approach the question whether these still point to a contribution to the disease.

Citing Articles

Mathematical modeling in autoimmune diseases: from theory to clinical application.

Ugolkov Y, Nikitich A, Leon C, Helmlinger G, Peskov K, Sokolov V Front Immunol. 2024; 15:1371620.

PMID: 38550585 PMC: 10973044. DOI: 10.3389/fimmu.2024.1371620.

Heat shock protein 90 (Hsp90) inhibitor STA-9090 (Ganetespib) ameliorates inflammation in a mouse model of atopic dermatitis.

Sitko K, Starke M, Tukaj S Cell Stress Chaperones. 2023; 28(6):935-942.

PMID: 37851180 PMC: 10746637. DOI: 10.1007/s12192-023-01387-0.

Inhibition of IL-17 ameliorates keratinocyte-borne cytokine responses in an in vitro model for house-dust-mite triggered atopic dermatitis.

Haertle J, Kienlin P, Begemann G, Werfel T, Roesner L Sci Rep. 2023; 13(1):16628.

PMID: 37789035 PMC: 10547677. DOI: 10.1038/s41598-023-42595-z.

Phototherapy and DNA Damage: A Systematic Review.

Oulee A, Ahn G, Javadi S, Wu J J Clin Aesthet Dermatol. 2023; 16(6):55-58.

PMID: 37361361 PMC: 10286878.

Spatial transcriptomics landscape of lesions from non-communicable inflammatory skin diseases.

Schabitz A, Hillig C, Mubarak M, Jargosch M, Farnoud A, Scala E Nat Commun. 2022; 13(1):7729.

PMID: 36513651 PMC: 9747967. DOI: 10.1038/s41467-022-35319-w.

References

Mayer C, Appenzeller U, Seelbach H, Achatz G, Oberkofler H, Breitenbach M . Humoral and cell-mediated autoimmune reactions to human acidic ribosomal P2 protein in individuals sensitized to Aspergillus fumigatus P2 protein. J Exp Med. 1999; 189(9):1507-12. PMC: 2193053. DOI: 10.1084/jem.189.9.1507. View

Ohkouchi K, Mizutani H, Tanaka M, Takahashi M, Nakashima K, Shimizu M . Anti-elongation factor-1alpha autoantibody in adult atopic dermatitis patients. Int Immunol. 1999; 11(10):1635-40. DOI: 10.1093/intimm/11.10.1635. View

Arstila T, Casrouge A, Baron V, Even J, Kanellopoulos J, Kourilsky P . A direct estimate of the human alphabeta T cell receptor diversity. Science. 1999; 286(5441):958-61. DOI: 10.1126/science.286.5441.958. View

RAMMENSEE H, Bachmann J, Emmerich N, Bachor O, Stevanovic S . SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics. 1999; 50(3-4):213-9. DOI: 10.1007/s002510050595. View

de Visser K, Cordaro T, Kioussis D, Haanen J, Schumacher T, Kruisbeek A . Tracing and characterization of the low-avidity self-specific T cell repertoire. Eur J Immunol. 2000; 30(5):1458-68. DOI: 10.1002/(SICI)1521-4141(200005)30:5<1458::AID-IMMU1458>3.0.CO;2-2. View

Ochs R, Muro Y, Si Y, Ge H, Chan E, Tan E . Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions. J Allergy Clin Immunol. 2000; 105(6 Pt 1):1211-20. DOI: 10.1067/mai.2000.107039. View

Sahaf B, Rosen A . Secretion of 10-kDa and 12-kDa thioredoxin species from blood monocytes and transformed leukocytes. Antioxid Redox Signal. 2001; 2(4):717-26. DOI: 10.1089/ars.2000.2.4-717. View

Fluckiger S, Fijten H, Whitley P, Blaser K, Crameri R . Cyclophilins, a new family of cross-reactive allergens. Eur J Immunol. 2001; 32(1):10-7. DOI: 10.1002/1521-4141(200201)32:1<10::AID-IMMU10>3.0.CO;2-I. View

Fluckiger S, Scapozza L, Mayer C, Blaser K, Folkers G, Crameri R . Immunological and structural analysis of IgE-mediated cross-reactivity between manganese superoxide dismutases. Int Arch Allergy Immunol. 2002; 128(4):292-303. DOI: 10.1159/000063862. View

10.

Mossabeb R, Seiberler S, Mittermann I, Reininger R, Spitzauer S, Natter S . Characterization of a novel isoform of alpha-nascent polypeptide-associated complex as IgE-defined autoantigen. J Invest Dermatol. 2002; 119(4):820-9. DOI: 10.1046/j.1523-1747.2002.00518.x. View

11.

Hashem N, Hirschhorn K, SEDLIS E, HOLT Jr L . Infantile eczema. Evidence of autoimmunity to human skin. Lancet. 1963; 2(7302):269-70. DOI: 10.1016/s0140-6736(63)90171-5. View

12.

Dornmair K, Goebels N, Weltzien H, Wekerle H, Hohlfeld R . T-cell-mediated autoimmunity: novel techniques to characterize autoreactive T-cell receptors. Am J Pathol. 2003; 163(4):1215-26. PMC: 1868314. DOI: 10.1016/S0002-9440(10)63481-5. View

13.

Szakos E, Lakos G, Aleksza M, Gyimesi E, Pall G, Fodor B . Association between the occurrence of the anticardiolipin IgM and mite allergen-specific IgE antibodies in children with extrinsic type of atopic eczema/dermatitis syndrome. Allergy. 2004; 59(2):164-7. DOI: 10.1046/j.1398-9995.2003.00367.x. View

14.

Kerschenlohr K, Darsow U, Burgdorf W, Ring J, Wollenberg A . Lessons from atopy patch testing in atopic dermatitis. Curr Allergy Asthma Rep. 2004; 4(4):285-9. DOI: 10.1007/s11882-004-0072-7. View

15.

Schmid-Grendelmeier P, Fluckiger S, Disch R, Trautmann A, Wuthrich B, Blaser K . IgE-mediated and T cell-mediated autoimmunity against manganese superoxide dismutase in atopic dermatitis. J Allergy Clin Immunol. 2005; 115(5):1068-75. DOI: 10.1016/j.jaci.2005.01.065. View

16.

Aichberger K, Mittermann I, Reininger R, Seiberler S, Swoboda I, Spitzauer S . Hom s 4, an IgE-reactive autoantigen belonging to a new subfamily of calcium-binding proteins, can induce Th cell type 1-mediated autoreactivity. J Immunol. 2005; 175(2):1286-94. DOI: 10.4049/jimmunol.175.2.1286. View

17.

Mothes N, Niggemann B, Jenneck C, Hagemann T, Weidinger S, Bieber T . The cradle of IgE autoreactivity in atopic eczema lies in early infancy. J Allergy Clin Immunol. 2005; 116(3):706-9. DOI: 10.1016/j.jaci.2005.06.025. View

18.

Schwienbacher M, Israel L, Heesemann J, Ebel F . Asp f6, an Aspergillus allergen specifically recognized by IgE from patients with allergic bronchopulmonary aspergillosis, is differentially expressed during germination. Allergy. 2005; 60(11):1430-5. DOI: 10.1111/j.1398-9995.2005.00904.x. View

19.

Moutaftsi M, Peters B, Pasquetto V, Tscharke D, Sidney J, Bui H . A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus. Nat Biotechnol. 2006; 24(7):817-9. DOI: 10.1038/nbt1215. View

20.

Limacher A, Glaser A, Meier C, Schmid-Grendelmeier P, Zeller S, Scapozza L . Cross-reactivity and 1.4-A crystal structure of Malassezia sympodialis thioredoxin (Mala s 13), a member of a new pan-allergen family. J Immunol. 2006; 178(1):389-96. DOI: 10.4049/jimmunol.178.1.389. View